CEP 12 SpectrumOrange


Product Overview

CEP 12 SpectrumOrange
Vysis - 07J22-012


Device Description

A defined piece of single-stranded nucleic acid which is used to identify specific complementary sequence nucleic acid molecules in an assay intended to be used to evaluate a clinical specimen to diagnose, monitor or predict chronic lymphocytic leukaemia (CLL) based on changes at the gene or chromosomal level, which may involve genetic markers on chromosomes 11, 12, 13 and 17.


Environmental Conditions

  • Special Storage Condition, Specify
    • Store unopened probe kit protected from light and humidity. Store 20X SSC salts and NP - 40 at room temperature. Store Slides in a sealed container with desiccant protected from humidity.
  • Storage Environment Temperature - Degrees Celsius
    • -20.00
    • -20.00

  • Device Sizes

    No Data Available


    Device Sterilization

    Device Sterile: False

    Sterilization Prior To Use: False

    Sterilization Methods: No Data Available


    Product Codes

    Code: KIR

    Device Name: Cells, Animal And Human, Cultured

    Device Class: 1

    Physical State: N/A

    Definition: N/A

    Submission Type ID: 4

    Review Panel: PA

    Review Code: N/A

    Technical Method: N

    Gmp Exempt Flag: N/A

    Life Sustain Support Flag: N

    Unclassified Reason: N/A

    Implant Flag: N

    Target Area: N/A

    Regulation Number: 864.2280

    Third Party Flag: N

    Medical Specialty: HE


    Code: OVQ

    Device Name: Chronic Lymphocytic Leukemia Fish Probe Kit

    Device Class: 2

    Physical State: Reagents for B-cell chronic lymphocytic leukemia prognosis

    Definition: The CLL FISH Probe Kit is intended to detect deletion of the LSI TP53, LSI ATM, and LSI D13S319 probe targets and gain of the D12Z3 sequence in peripheral blood specimens from untreated patients with B-cell chronic lymphocytic leukemia (CLL). The assay may be used to dichotomize CLL (the 13q-, +12, or normal genotype group versus the 11q- or 17p- group) and may be used as an aid in determining disease prognosis in combination with additional biomarkers, morphology and other clinical information.

    Submission Type ID: 1

    Review Panel: PA

    Review Code: N/A

    Technical Method: N

    Gmp Exempt Flag: Fluorescent in situ hybridization

    Life Sustain Support Flag: N

    Unclassified Reason: N/A

    Implant Flag: N

    Target Area: B-cell chronic lymphocytic leukemia

    Regulation Number: 866.6040

    Third Party Flag: Y

    Medical Specialty: IM


    Device Identifiers

    Device Id: 00884999027084

    Device Type: Primary

    DeviceId Issuing Agency: GS1

    Contains DI Number: N/A

    Package Quantity: N/A

    Package Discontinue Date: N/A

    Package Status: N/A

    Package Type: N/A


    GMDN ®. © GMDN Agency 2005-2024.
    Educational Resources
    Videos